Results 241 to 250 of about 47,222 (292)

Prevalence of Bodily Distress Syndrome and Prediction of Patient Outcomes: Cohort Study of 3762 Individuals With Persistent Pain

open access: yesEuropean Journal of Pain, Volume 30, Issue 2, February 2026.
ABSTRACT Background Persistent physical symptoms are common and often result in disability and high healthcare use. To capture how such symptoms co‐occur, Bodily Distress Syndrome (BDS, also called Functional Somatic Disorders) was developed as an empirically derived construct, in contrast to consensus‐based syndromes such as fibromyalgia and chronic ...
Live Landmark   +4 more
wiley   +1 more source

Peripheral Blood Skin‐Homing T Cells Define Immunological Endotypes in Atopic Dermatitis: A Case–Control Study in a Mexican Population

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Atopic dermatitis (AD) is a chronic inflammatory skin disease with marked immunological heterogeneity. T‐cell subsets expressing CLA, CCR4, and CCR10 are involved in skin inflammation, but their frequency and expression patterns in AD remain poorly characterized.
Zumaya‐Pérez Luis Carlos   +6 more
wiley   +1 more source

Cost‐Utility of Pharmacist‐Led Deprescribing Interventions for Community‐Dwelling Older Adults: A Systematic Review

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 2, February 2026.
ABSTRACT Background Inappropriate medications continue to be dispensed to older adults. Deprescribing is an intervention carried out under the supervision of a health care professional, where medications that may cause harm or are no longer beneficial are reduced or withdrawn.
Chiranjeev Sanyal   +2 more
wiley   +1 more source

How Pragmatic Are Sarcopenia Intervention Studies? A Systematic Review

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Sarcopenia is an age‐related muscle disease often accompanied by comorbidities, mobility issues and cognitive decline, which can limit treatment adherence in older adults. Owing to the reversible nature of sarcopenia, there has been a growing number of randomized controlled trials conducted in recent years.
Sophie Van Heden   +4 more
wiley   +1 more source

Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma‐Based Diagnostic Models of Sarcopenia

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Sarcopenia is a progressive, age‐related condition characterized by a decline in skeletal muscle mass, strength and performance. Diagnosis remains challenging because current consensus criteria are difficult to scale and existing biomarkers lack accuracy.
Dongqin Xu   +10 more
wiley   +1 more source

Does lifestyle explain the relationship between socioeconomic position and multimorbidity of cancer and cardiometabolic diseases? A mediation analysis applied to the European Prospective Investigation into Cancer and Nutrition. [PDF]

open access: yesJ Epidemiol Community Health
Manfredi L   +29 more
europepmc   +1 more source

Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Sarcopenia, an important complication of chronic obstructive pulmonary disease (COPD), is significantly associated with increased mortality. Systemic inflammation is an important trigger of COPD‐related skeletal muscle dysfunction. Calprotectin is a damage‐associated molecular pattern involved in the inflammatory response, but its ...
Liwei Liao   +9 more
wiley   +1 more source

Lifestyle, air pollution, and risk of multimorbidity in a prospective analysis of the UK Biobank cohort

open access: gold
Fei Chen   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy